Current Treatment Options for Acute Skin and Skin-structure Infections
- PMID: 30957166
- PMCID: PMC6451992
- DOI: 10.1093/cid/ciz004
Current Treatment Options for Acute Skin and Skin-structure Infections
Abstract
Acute bacterial skin and skin-structure infections (ABSSSIs) are a common reason for seeking care at acute healthcare facilities, including emergency departments. Staphylococcus aureus is the most common organism associated with these infections, and the emergence of community-associated methicillin-resistant Staphylococcus aureus (MRSA) has represented a considerable challenge in their treatment. To address this need, a number of new antibiotics have been developed for the treatment of ABSSSIs in the past several years. Most of these agents focus primarily on gram-positive organisms, particularly MRSA; however, there has not been an oral agent that can reliably treat MRSA, as well as relevant gram-negative pathogens. Acute skin infections that involve mixed gram-positive and gram-negative pathogens must also be considered as they can be associated with discordant antimicrobial therapy. Here, I review ABSSSI treatment guidelines in the hospital setting and discuss current and future antibiotic options for treatment of this commonly encountered infection.
Keywords: abscess; antibiotic resistance; skin infection; therapy.
© The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America.
References
-
- Russo A, Concia E, Cristini F, et al. . Current and future trends in antibiotic therapy of acute bacterial skin and skin-structure infections. Clin Microbiol Infect 2016; 22 Suppl 2:S27–36. - PubMed
-
- Pollack CV Jr, Amin A, Ford WT Jr, et al. . Acute bacterial skin and skin structure infections (ABSSSI): practice guidelines for management and care transitions in the emergency department and hospital. J Emerg Med 2015; 48:508–19. - PubMed
-
- Esposito S, Bassetti M, Concia E, et al. ; Italian Society of Infectious and Tropical Diseases Diagnosis and management of skin and soft-tissue infections (SSTI). A literature review and consensus statement: an update. J Chemother 2017; 29:197–214. - PubMed
-
- US Food and Drug Administration. Acute bacterial skin and skin structure infections: developing drugs for treatment. Guidance for industry. 2013. Available at: https://www.fda.gov/downloads/Drugs/Guidances/ucm071185.pdf. Accessed 15 March 2019.
-
- Abrahamian FM, Talan DA, Moran GJ. Management of skin and soft-tissue infections in the emergency department. Infect Dis Clin North Am 2008; 22:89–116, vi. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
